Maxcyte (DI) (MXCT)



  • Change Today:
  • 52 Week High: 420.00p
  • 52 Week Low: 210.00p
  • Currency: UK Pounds
  • Shares Issued: 104.82m
  • Volume: 11,350
  • Market Cap: 381.56m

Maxcyte (DI) Overview

We are a U.S.-based global company driving the acceleration of the discovery/development, manufacturing and commercialization of next-generation, cell-based medicines. We understand and scientifically solve partners challenges by applying our expertise.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart


Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -117.0% -162.1%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 11.9 10.6
Pr/Book 2.1  
Latest F'cast
Revenue -60.9% -32.6%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Maxcyte (DI) Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 21.62 (12.89) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-20 26.00 (11.82) (17.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 33.89 (19.08) (21.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 44.26 (23.57) (54.87)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 41.29 (37.92) (37.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Maxcyte (DI) Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 35.93 (58.23) (35.93)p n/a n/a n/a n/a 0.0%
31-Dec-25 45.59 (52.37) (33.23)p n/a n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Maxcyte (DI) Company Announcements

Notice of Results 10-Jul-2024 09:15 RNS
Change of Name of Nominated Adviser and Broker 09-Jul-2024 09:14 RNS
TR-1: Notification of major holdings 03-Jul-2024 07:00 RNS

Latest Maxcyte (DI) Director Deals

Traded Action Notifier PriceAmountValue
27-Jun-24 Sell John Johnston 315.63p 10,000 31,562.87
27-Jun-24 Exercise of option John Johnston 231.47p 4,956 11,471.79
27-Jun-24 Exercise of option John Johnston 129.82p 5,044 6,548.01

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.


Maxcyte (DI) Market Data

Currency UK Pounds
Share Price 364.00p
Change Today -16.00p
% Change -4.21 %
52 Week High 420.00p
52 Week Low 210.00p
Volume 11,350
Shares Issued 104.82m
Market Cap 381.56m

Maxcyte (DI) Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value Not Available
Price Trend Not Available
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 4
Buy 3
Neutral 0
Sell 0
Strong Sell 0
Total 7
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Maxcyte (DI) Dividends

No dividends found

Trades for 19-Jul-2024

Time Volume / Share Price
15:15 484 @ 360.11p
15:07 484 @ 360.11p
14:53 695 @ 360.11p
14:43 3,336 @ 360.10p
14:38 750 @ 370.00p

Top of Page